NB-598 hydrochloride is used as a competitive inhibitor of squalene epoxidase (SE) to suppress cholesterol and triacylglycerol biosynthesis; it reduces total cholesterol levels in MIN6 cells; decreases cholesterol content in plasma membrane (PM), endoplasmic reticulum (ER), and secretory granules (SG); inhibits insulin secretion under both basal and glucose-stimulated conditions; suppresses sterol and sterol ester synthesis from [14C]acetate without affecting phospholipids, free fatty acids, or triacylglycerol synthesis; reduces ACAT activity in the presence or absence of exogenous liposomal cholesterol; and inhibits the secretion of cholesterol and triacylglycerol from HepG2 cells into the medium.